scholarly article | Q13442814 |
P50 | author | Alexander Pichugin | Q56424754 |
Alexander Apt | Q59668298 | ||
P2093 | author name string | Elena Kondratieva | |
David McMurray | |||
Svetlana Petrovskaya | |||
Irina Baturina | |||
Tatiana Kondratieva | |||
Elvira Rubakova | |||
Valentine Khlebnikov | |||
P2860 | cites work | Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model | Q24675231 |
Dendritic cells and the control of immunity | Q27860918 | ||
Immunology of tuberculosis | Q29614370 | ||
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
The dendritic cell system and its role in immunogenicity | Q29619870 | ||
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo | Q30080006 | ||
Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice | Q33715964 | ||
An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis | Q33766722 | ||
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin | Q33919973 | ||
Interaction of dendritic cells with mycobacteria: where the action starts | Q34007420 | ||
Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis | Q34008163 | ||
Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A. | Q34119135 | ||
Variation in protection by BCG: implications of and for heterologous immunity | Q34288541 | ||
Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis | Q34338450 | ||
Immunity to tuberculosis | Q35698525 | ||
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ | Q36352646 | ||
Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo | Q36362128 | ||
A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice | Q37623702 | ||
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis | Q38447962 | ||
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
Dendritic cells acquire antigens from live cells for cross-presentation to CTL. | Q40822225 | ||
Immunological requirements for a subunit vaccine against tuberculosis | Q40867776 | ||
Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice | Q40894562 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. | Q41355790 | ||
Florid pulmonary inflammatory responses in mice vaccinated with Antigen-85 pulsed dendritic cells and challenged by aerosol with Mycobacterium tuberculosis | Q44420174 | ||
Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice | Q44445984 | ||
Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice. | Q54044422 | ||
Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens fromMycobacterium tuberculosis | Q57203132 | ||
Cytolytic T-cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin | Q57598880 | ||
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature | Q57752071 | ||
Bacille Calmette-Guérin adenitis 30 years after immunization in a patient with AIDS | Q69753233 | ||
Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo | Q73100730 | ||
Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination protocols | Q73579418 | ||
Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells | Q77924901 | ||
Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection | Q79317485 | ||
Close encounters of neutrophils and DCs | Q81257740 | ||
Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha production | Q81621894 | ||
The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation? | Q81795301 | ||
P433 | issue | 2 | |
P921 | main subject | dendritic cell | Q506253 |
tuberculosis | Q12204 | ||
P304 | page(s) | 134-144 | |
P577 | publication date | 2006-10-02 | |
P1433 | published in | Tuberculosis | Q15757844 |
P1476 | title | Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model | |
P478 | volume | 87 |
Q37371021 | Antigen-presenting cells transfected with Hsp65 messenger RNA fail to treat experimental tuberculosis. |
Q38887861 | Overview of dendritic cell-based vaccine development for leishmaniasis |
Q28473223 | Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells |
Q37746200 | Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice. |
Q37652470 | The role of dendritic cells in mycobacterium-induced granulomas |
Q50656736 | Therapeutic protein deimmunization by T-cell epitope removal: antigen-specific immune responses in vitro and in vivo. |
Q37754908 | Tuberculosis vaccines: present and future |
Search more.